Antares Pharma (ATRS) Reports In-Line Q2 EPS

August 9, 2016 7:50 AM EDT
Get Alerts ATRS Hot Sheet
Price: $2.02 -2.42%

Today's EPS Names:
SIGM, HQY, XTLB, More
Trade ATRS Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Antares Pharma (NASDAQ: ATRS) reported Q2 EPS of ($0.04), in-line with the analyst estimate of ($0.04). Revenue for the quarter came in at $12.2 million versus the consensus estimate of $11 million.

For earnings history and earnings-related data on Antares Pharma (ATRS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment